Flora Growth (FLGC) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Flora Growth Revenue Highlights


Latest Revenue (Y)

$76.07M

Latest Revenue (Q)

$15.68M

Main Segment (Y)

Pharmaceuticals and Nutraceuticals

Main Geography (Y)

GERMANY

Flora Growth Revenue by Period


Flora Growth Revenue by Year

DateRevenueChange
2023-12-31$76.07M104.65%
2022-12-31$37.17M313.93%
2021-12-31$8.98M8371.70%
2020-12-31$106.00K100.00%
2019-12-31--

Flora Growth generated $76.07M in revenue during NA 2023, up 104.65% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Flora Growth Revenue by Quarter

DateRevenueChange
2024-06-30$15.68M-13.02%
2024-03-31$18.03M0.31%
2023-12-31$17.98M3.80%
2023-09-30$17.32M-19.31%
2023-06-30$21.46M6.73%
2023-03-31$20.11M75.01%
2022-12-31$11.49M6.73%
2022-09-30$10.77M7.96%
2022-06-30$9.97M101.60%
2022-03-31$4.95M3.71%
2021-12-31$4.77M127.85%
2021-09-30$2.09M80.59%
2021-06-30$1.16M9.44%
2021-03-31$1.06M1898.11%
2020-12-31$53.00K-
2020-09-30$53.00K100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-06-30--

Flora Growth generated $15.68M in revenue during Q2 2024, up -13.02% compared to the previous quarter, and up 78.00% compared to the same period a year ago.

Flora Growth Revenue Breakdown


Flora Growth Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21
Pharmaceuticals and Nutraceuticals$2.34M

Flora Growth's latest annual revenue breakdown by segment (product or service), as of Dec 21: Pharmaceuticals and Nutraceuticals (100.00%).

Flora Growth Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 21
UNITED STATES$36.54M-
GERMANY$38.26M-
United States-$1.68M
Pharmaceuticals and Nutraceuticals-$2.34M
Canada-$380.00K

Flora Growth's latest annual revenue breakdown by geography, as of Dec 23: GERMANY (51.15%), and UNITED STATES (48.85%).

Quarterly Revenue by Country

CountryMar 24Dec 23Jun 23
GERMANY$11.34M$27.46M$10.80M
UNITED STATES$6.52M$26.18M$10.35M

Flora Growth's latest quarterly revenue breakdown by geography, as of Mar 24: GERMANY (63.51%), and UNITED STATES (36.49%).

Flora Growth Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.39M
INCRInterCure$355.55M$73.47M
FLGCFlora Growth$76.07M$15.68M
SBFMSunshine Biopharma$39.85M$9.30M
TKNOAlpha Teknova$36.68M$9.61M
CLVRClever Leaves$17.42M$4.64M
SNOASonoma Pharmaceuticals$12.73M$3.44M
GHSIGuardion Health Sciences$12.25M$36.35K
PRFXPainReform--

FLGC Revenue FAQ


Flora Growth's yearly revenue for 2023 was $76.07M, representing an increase of 104.65% compared to 2022. The company's yearly revenue for 2022 was $37.17M, representing an increase of 313.93% compared to 2021. FLGC's yearly revenue for 2021 was $8.98M, representing an increase of 8371.70% compared to 2020.

Flora Growth's quarterly revenue for Q2 2024 was $15.68M, a -13.02% decrease from the previous quarter (Q1 2024), and a -26.92% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $18.03M, a 0.31% increase from the previous quarter (Q4 2023), and a -10.32% decrease year-over-year (Q1 2023). FLGC's quarterly revenue for Q4 2023 was $17.98M, a 3.80% increase from the previous quarter (Q3 2023), and a 56.45% increase year-over-year (Q4 2022).

Flora Growth's revenue growth rate for the last 3 years (2021-2023) was 747.12%, and for the last 5 years (2019-2023) was 0%.

Flora Growth's revenue streams in c 21 are Pharmaceuticals and Nutraceuticals

For the fiscal year ending Dec 21, the largest source of revenue of Flora Growth was Pharmaceuticals and Nutraceuticals. This segment made a revenue of $2.34M, representing 100.00% of the company's total revenue.